Apr. ZEYREK SRL
Apr. ZEYREK reported total assets of 72,982 € at the end of the 2025 financial year (annual accounts filed with the NBB on 16 Jun 2026).
The score of Apr. ZEYREK shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Accounts of the company itself (not consolidated).
The full file covers 2 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Apr. ZEYREK's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 16 Jun 2026
- Year ended 31 Dec 2024filed on 16 Jun 2025
Apr. ZEYREK's financial analysis
- Solvency73.5%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Apr. ZEYREK
Apr. ZEYREK's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 1000.003.880
- VAT number
- BE1000003880
- Peppol
- Registered · 0208:1000003880 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 19 Sep 2023
- Registered office
- 3000 Leuven
- Latest accounts
- 2025 · filed on 16 Jun 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Apr. ZEYREK (SRL) has been based in Leuven since 2023, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 17,347 € and equity of 53,627 €; its revenue is not published. Its solvency stands at 73.5%, above the median of its sector (44.2%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Apr. ZEYREK
Companies in the same business, of comparable size and area, outside its group.
- DD Pharma Retail sale of pharmaceutical products Leuven · balance sheet 75,776 €
- Apotheker Van De Weghe Karen Retail sale of pharmaceutical products Sint-Martens-Latem · balance sheet 73,167 €
- LouksPharma Retail sale of pharmaceutical products Fernelmont · balance sheet 72,654 €
- Arkophar Retail sale of pharmaceutical products Zutendaal · balance sheet 73,718 €
- Sirrah Retail sale of pharmaceutical products Tournai · balance sheet 84,897 €
- Carva Care Retail sale of pharmaceutical products Heist-op-den-Berg · balance sheet 72,190 €
- Sagenex Retail sale of pharmaceutical products Namur · balance sheet 73,820 €
- Arucarea Retail sale of pharmaceutical products Oud-Turnhout · balance sheet 73,983 €
Frequently asked questions about Apr. ZEYREK
What is the revenue of Apr. ZEYREK?
Apr. ZEYREK files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Apr. ZEYREK?
In Belgium, the VAT number is the company number prefixed with BE: BE1000003880 for Apr. ZEYREK, if the company is VAT-registered. Its company number (CBE) is 1000.003.880.
Where is the registered office of Apr. ZEYREK?
According to the CBE register, the registered office of Apr. ZEYREK is in 3000 Leuven.
What is the equity of Apr. ZEYREK?
At the close of the 2025 financial year, the equity of Apr. ZEYREK amounts to 53,627 €, a solvency of 73.5% of total assets.
Who manages Apr. ZEYREK?
The register lists 1 active mandates at Apr. ZEYREK. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Apr. ZEYREK
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →